Assessment of Gonadal Functions in Uremic Male Patients

Status Not yet recruiting

Clinical Trial Summary

1. Study the prevalence of sexual dysfunction in male patients on hemodialysis aged 18-60 years (sexually active male) . 2. Study the effect of hemodialysis on the male patients sexual functions by measurement of serum prolactin and free testosterone levels.

Clinical Trial Description

: Gonadal dysfunction is a frequent finding in men with ESRD on chronic hemodialysis ,erectile dysfunction is one of the most common manifestation of sexual dysfuncion whitch has been reported to be as high as 70 -80 %of hemodialysis patients . Testosterone deficiency and insufficiency are frequent findings in hemodialysis male patients that were found to be 66% and 24% respectively The Probleme is multifactorial , the most important factor is due to testesterone deficiency. total and free testosterone levels are typically reduced , that is usually accompanied by elevation of serum Gonadotropins concentrations due to hypothalamic -pituitary-gonadal -axis disturbance(uremic hypogonadism) . Alterations in the pulsatile release of GnRH, which leads to a hypogondal state due to uremia, which occurs due to inadequate nutrient intake, stress, and systemic illness . Excess LH secretion is thought to result from the diminished release of testosterone from the Leydig cells, because testosterone normally provides a feedback inhibition of LH release. The metabolic clearance rate of LH is reduced due to reduction of kidney clearance ,Follicle stimulating hormone (FSH) secretion is also increased in men with chronic kidney failure. Elevated plasma prolactin levels are commonly found in dialyzed men, it is thought to be due to increased its production , extreme hyperprolactinemia has been associated with infertility, loss of libido, low circulating testosterone levels, So,due to testosterone deficiency and hyperprolactinemia in ESRD as one of most important factors and exclusion of other factors , men on chronic hemodialysis shows different degrees of subfertility or infertility due to Erectile dysfunction , testicular damage and impaired spermatogenesis. ;

Study Design

Related Conditions & MeSH terms

ESRD

Clinical Trial Details

NCT number	NCT04710238
Study type	Observational [Patient Registry]
Source	Assiut University
Contact	ali setohy hussien, M.B.B.ch
Phone	01020462809
Email	setohy94@gmail.com
Status	Not yet recruiting
Phase
Start date	February 1, 2021
Completion date	February 28, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03246984` - VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ	N/A
Completed	`NCT03943212` - The Effect of Blood Flow Rate on Dialysis Recovery Time in Patients Undergoing Maintenance Hemodialysis	N/A
Completed	`NCT03456648` - Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study	Phase 2
Completed	`NCT00966615` - The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition	Phase 4
Completed	`NCT01252771` - Phosphate Kinetic Modeling 2	Phase 4
Completed	`NCT00850252` - Use of a Lifeline Graft in the A-V Shunt Model	Phase 1/Phase 2
Completed	`NCT00294502` - Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia	Phase 4
Completed	`NCT05011136` - Physician Reimbursement Home Patients
Completed	`NCT05144971` - StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation
Completed	`NCT02278562` - Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2	Phase 2
Completed	`NCT01424787` - Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering)	N/A
Terminated	`NCT00580762` - Bariatric Surgery for ESRD Patients vs Control	N/A
Recruiting	`NCT05339139` - SAfety of Regional Citrate Anticoagulation (SARCA Study)	Phase 3
Completed	`NCT03242343` - VasQ External Support for Arteriovenous Fistula	N/A
Recruiting	`NCT05309785` - Safety and Efficacy of Canagliflozin in Advanced CKD	Phase 4
Completed	`NCT02966028` - Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)	Phase 2
Not yet recruiting	`NCT02596386` - Examination of Potassium Levels in Saliva in ESRD Patients	N/A
Completed	`NCT02513303` - Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes	Phase 3
Active, not recruiting	`NCT02270515` - Bringing Care to Patients: Patient-Centered Medical Home for Kidney Disease	N/A
Recruiting	`NCT06001827` - SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.